These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 10752656)
1. Telomerase, p53 and human papillomavirus infection in the uterine cervix. Nair P; Jayaprakash PG; Nair MK; Pillai MR Acta Oncol; 2000; 39(1):65-70. PubMed ID: 10752656 [TBL] [Abstract][Full Text] [Related]
2. Increased angiogenesis in the uterine cervix associated with human papillomavirus infection. Nair P; Gangadevi T; Jayaprakash PG; Nair MB; Nair MK; Pillai MR Pathol Res Pract; 1999; 195(3):163-9. PubMed ID: 10220796 [TBL] [Abstract][Full Text] [Related]
3. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix. Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239 [TBL] [Abstract][Full Text] [Related]
4. Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Nair P; Nair KM; Jayaprakash PG; Pillai MR Pathol Oncol Res; 1999; 5(2):95-103. PubMed ID: 10393359 [TBL] [Abstract][Full Text] [Related]
5. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix. Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662 [TBL] [Abstract][Full Text] [Related]
6. Expression of HPV-16 E6 protein and p53 inactivation increases the uterine cervical cancer invasion. Yang X; Lu L Drug Res (Stuttg); 2015 Feb; 65(2):70-3. PubMed ID: 24831244 [TBL] [Abstract][Full Text] [Related]
7. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. Kurvinen K; Syrjänen K; Syrjänen S J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer. Singh A; Sharma H; Salhan S; Gupta SD; Bhatla N; Jain SK; Singh N Pathobiology; 2004; 71(6):314-22. PubMed ID: 15627842 [TBL] [Abstract][Full Text] [Related]
9. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors. Pillai MR; Nair MK Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364 [TBL] [Abstract][Full Text] [Related]
10. Cellular manifestations of human papillomavirus infection in the oral mucosa. Pillai MR; Phanidhara A; Kesari AL; Nair P; Nair MK J Surg Oncol; 1999 May; 71(1):10-5. PubMed ID: 10362085 [TBL] [Abstract][Full Text] [Related]
11. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients. Cheah PL; Looi LM; Ng MH; Sivanesaratnam V J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919 [TBL] [Abstract][Full Text] [Related]
12. Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma. Sima N; Cai L; Zhu Y; Wang W; Wang S; Ma D J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):451-3. PubMed ID: 17828509 [TBL] [Abstract][Full Text] [Related]
13. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563 [TBL] [Abstract][Full Text] [Related]
14. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506 [TBL] [Abstract][Full Text] [Related]
15. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [TBL] [Abstract][Full Text] [Related]
16. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588 [TBL] [Abstract][Full Text] [Related]
17. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix. Riethdorf S; Riethdorf L; Schulz G; Ikenberg H; Jänicke F; Löning T; Park TW Int J Gynecol Pathol; 2001 Apr; 20(2):177-85. PubMed ID: 11293165 [TBL] [Abstract][Full Text] [Related]
18. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus]. Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the p53 gene and papillomavirus detection in smears from cervical lesions. dos Santos Oliveira Ldo H; Fernandez Ade P; Xavier BL; Machado Rodrigues Ede V; Cavalcanti SM Sao Paulo Med J; 2002 Jan; 120(1):20-2. PubMed ID: 11836549 [TBL] [Abstract][Full Text] [Related]
20. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]